Insomnia Treatment with Eszopiclone

Clinical Efficacy

• Studies demonstrate clinically significant reduction in objective sleep latency and increased subjective total sleep time, as recommended by the American Academy of Sleep Medicine 1

Comparison to Other Sleep Medications

• Eszopiclone is considered a first-line pharmacological option for insomnia, along with other short/intermediate-acting benzodiazepine receptor agonists, according to the American Academy of Sleep Medicine 2
• Unlike some shorter-acting agents, eszopiclone's relatively longer half-life makes it more effective for sleep maintenance issues, as noted by the American Academy of Sleep Medicine 2

Clinical Practice Algorithm

• If cognitive behavioral therapy for insomnia (CBT-I) is unsuccessful or unavailable, consider pharmacotherapy with eszopiclone, as suggested by the American Academy of Sleep Medicine, although this particular point is from a different source it is kept for context 2